Co-pay Assistance Programs Update (11/11/19)

What Is Multiple Myeloma?

Multiple myeloma is a cancer of the bone marrow plasma cells. It is synonymous with "myeloma" and "plasma cell myeloma." Plasma cells make antibodies against infectious agents such as viruses and bacteria. A cancerous or malignant plasma cell is called a myeloma cell. Myeloma is called “multiple” because there are frequently multiple patches or areas in bone marrow where it grows.

As of November 11, 2019:

Healthwell has available funds for their co-pay assistance program. To learn if you qualify and how to apply, visit this Healthwell page.

The Leukemia & Lymphoma Society (LLS) has available funds for their co-pay assistance program. To learn if you qualify and how to apply, visit this LLS page.

The Patient Advocate Foundation (PAF) has available funds for their co-pay assistance program. To learn if you qualify and how to apply, visit this PAF page.

Patient Access Network Foundation (PANF) has available funds for their co-pay assistance program. To learn if you qualify and how to apply, visit this Patient Access Network Foundation page.

However, many other co-pay assistance programs are still unable to assist patients. If you have an existing grant, please check its status with that co-pay foundation. Links provided below:

CancerCare

Good Days

If you are in need of co-pay assistance, we also encourage you to contact the patient support programs of the drug manufacturers directly:

Celgene